These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19285083)

  • 21. KCNJ2 mutation causes an adrenergic-dependent rectification abnormality with calcium sensitivity and ventricular arrhythmia.
    Kalscheur MM; Vaidyanathan R; Orland KM; Abozeid S; Fabry N; Maginot KR; January CT; Makielski JC; Eckhardt LL
    Heart Rhythm; 2014 May; 11(5):885-94. PubMed ID: 24561538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Kir2.1E299V mutation increases atrial fibrillation vulnerability while protecting the ventricles against arrhythmias in a mouse model of short QT syndrome type 3.
    Moreno-Manuel AI; Macías Á; Cruz FM; Gutiérrez LK; Martínez F; González-Guerra A; Martínez Carrascoso I; Bermúdez-Jimenez FJ; Sánchez-Pérez P; Vera-Pedrosa ML; Ruiz-Robles JM; Bernal JA; Jalife J
    Cardiovasc Res; 2024 Apr; 120(5):490-505. PubMed ID: 38261726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational Analysis of the Action of Chloroquine on Short QT Syndrome Variant 1 and Variant 3 in Human Ventricles.
    Luo C; Wang K; Liu T; Zhang H
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():5462-5465. PubMed ID: 30441573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of an inward rectifier channel (IKir) found in avian vestibular hair cells: cloning and expression of pKir2.1.
    Correia MJ; Wood TG; Prusak D; Weng T; Rennie KJ; Wang HQ
    Physiol Genomics; 2004 Oct; 19(2):155-69. PubMed ID: 15316115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural basis of drugs that increase cardiac inward rectifier Kir2.1 currents.
    Gómez R; Caballero R; Barana A; Amorós I; De Palm SH; Matamoros M; Núñez M; Pérez-Hernández M; Iriepa I; Tamargo J; Delpón E
    Cardiovasc Res; 2014 Nov; 104(2):337-46. PubMed ID: 25205296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia.
    Deo M; Ruan Y; Pandit SV; Shah K; Berenfeld O; Blaufox A; Cerrone M; Noujaim SF; Denegri M; Jalife J; Priori SG
    Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4291-6. PubMed ID: 23440193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azithromycin Causes a Novel Proarrhythmic Syndrome.
    Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Voltage-dependent gating and block by internal spermine of the murine inwardly rectifying K+ channel, Kir2.1.
    Matsuda H; Oishi K; Omori K
    J Physiol; 2003 Apr; 548(Pt 2):361-71. PubMed ID: 12640008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Computational Study to Identify the Effects of the KCNJ2 E299V Mutation in Cardiac Pumping Capacity.
    Jeong DU; Lee J; Lim KM
    Comput Math Methods Med; 2020; 2020():7194275. PubMed ID: 32328155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kir2.1 and K2P1 channels reconstitute two levels of resting membrane potential in cardiomyocytes.
    Zuo D; Chen K; Zhou M; Liu Z; Chen H
    J Physiol; 2017 Aug; 595(15):5129-5142. PubMed ID: 28543529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen inhibits inward rectifier K+ 2.x family of inward rectifier channels by interfering with phosphatidylinositol 4,5-bisphosphate-channel interactions.
    Ponce-Balbuena D; López-Izquierdo A; Ferrer T; Rodríguez-Menchaca AA; Aréchiga-Figueroa IA; Sánchez-Chapula JA
    J Pharmacol Exp Ther; 2009 Nov; 331(2):563-73. PubMed ID: 19654266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat.
    Zhai XW; Zhang L; Guo YF; Yang Y; Wang DM; Zhang Y; Li P; Niu YF; Feng QL; Wu BW; Cao JM; Liu QH
    PLoS One; 2017; 12(5):e0177600. PubMed ID: 28542320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore.
    Amorós I; Dolz-Gaitón P; Gómez R; Matamoros M; Barana A; de la Fuente MG; Núñez M; Pérez-Hernández M; Moraleda I; Gálvez E; Iriepa I; Tamargo J; Caballero R; Delpón E
    Biochem Pharmacol; 2013 Jul; 86(2):267-78. PubMed ID: 23648307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stretch-induced alterations of human Kir2.1 channel currents.
    He Y; Xiao J; Yang Y; Zhou Q; Zhang Z; Pan Q; Liu Y; Chen Y
    Biochem Biophys Res Commun; 2006 Dec; 351(2):462-7. PubMed ID: 17067550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome.
    Ballester LY; Vanoye CG; George AL
    Channels (Austin); 2007; 1(3):209-17. PubMed ID: 18690034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inward Rectifier Potassium Channels (Kir2.x) and Caveolin-3 Domain-Specific Interaction: Implications for Purkinje Cell-Dependent Ventricular Arrhythmias.
    Vaidyanathan R; Van Ert H; Haq KT; Morotti S; Esch S; McCune EC; Grandi E; Eckhardt LL
    Circ Arrhythm Electrophysiol; 2018 Jan; 11(1):e005800. PubMed ID: 29326130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac Kir2.1 and Na
    Ponce-Balbuena D; Guerrero-Serna G; Valdivia CR; Caballero R; Diez-Guerra FJ; Jiménez-Vázquez EN; Ramírez RJ; Monteiro da Rocha A; Herron TJ; Campbell KF; Willis BC; Alvarado FJ; Zarzoso M; Kaur K; Pérez-Hernández M; Matamoros M; Valdivia HH; Delpón E; Jalife J
    Circ Res; 2018 May; 122(11):1501-1516. PubMed ID: 29514831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome.
    Doi T; Makiyama T; Morimoto T; Haruna Y; Tsuji K; Ohno S; Akao M; Takahashi Y; Kimura T; Horie M
    Circ Cardiovasc Genet; 2011 Jun; 4(3):253-60. PubMed ID: 21493816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Andersen's syndrome mutants produce a knockdown of inwardly rectifying K
    Simkin D; Robin G; Giuliano S; Vukolic A; Moceri P; Guy N; Wagner KD; Lacampagne A; Allard B; Bendahhou S
    Cell Tissue Res; 2018 Feb; 371(2):309-323. PubMed ID: 29018970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).
    Tristani-Firouzi M; Jensen JL; Donaldson MR; Sansone V; Meola G; Hahn A; Bendahhou S; Kwiecinski H; Fidzianska A; Plaster N; Fu YH; Ptacek LJ; Tawil R
    J Clin Invest; 2002 Aug; 110(3):381-8. PubMed ID: 12163457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.